Enovis Corp

Organisation

2711 Centerville Road, Wilmington, DE, United States, 19808

Headquarters

7802

Employees

Capital Goods

Industry

Matthew Trerotola

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Price

Target

Enovis Corp (ENOV) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Enovis Corp (ENOV) share price will touch around $45.18 in next 12-months.

Currently 18 wall-street analysts regularly analyze the financials of Enovis Corp on a frequent basis to provide recommendations along with target share price. 18 analysts offering 12-month price forecasts for Enovis Corp (ENOV) have a share price target of $45.18. This median of share price forecast represents a 96.61% upside from the latest price of $22.98 as on 17.03.26.

Enovis Corp (ENOV) Share Price Forecast

Home

US Stocks

Enovis Corp (ENOV)

Enovis Corp Stock Forecast

Enovis Corp Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Enovis Corp (ENOV): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Enovis Corp's share price and its median forecast price. As on 17.03.26, the difference is -37.53%

Enovis Corp Forecast and Target Price

Enovis Corp (ENOV) Share Price Forecast

Enovis Corp (ENOV) Price vs Consensus Price Target

Enovis Corp (ENOV) Share Price Forecast v/s Share Price Today

Enovis Corp (ENOV): Difference between Current Price & Median Forecasted Price

Enovis Corp (ENOV) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price